0
SWAB logo

Antibioticabeleid

  1. Bauer MP, Kuijper EJ, van Dissel JT. European Society of Clinical Microbiology and Infectious Diseases (ESCMID): treatment guidance document for Clostridium difficile infection (CDI). Clin Microbiol Infect. 2009 Dec;15(12):1067-79.
  2. Bauer MP, van Dissel JT, Kuijper EJ. Clostridium difficile: controversies and approaches to management. Curr Opin Infect Dis. 2009 Dec;22(6):517-24.
  3. Bauer MP, Veenendaal D, Verhoef L, Bloembergen P, van Dissel JT, Kuijper EJ. Clinical and microbiological characteristics of community-onset Clostridium difficile infection in The Netherlands. Clin Microbiol Infect. 2009 Dec;15(12):1087-92.
  4. Van Doormaal JE, van den Bemt PM, Zaal RJ, Egberts AC, Lenderink BW, Kosterink JG, Haaijer-Ruskamp FM, Mol PG. The influence that electronic prescribing has on medication errors and preventable adverse drug events: an interrupted time-series study. J Am Med Inform Assoc. 2009 Nov-Dec;16(6):816-25.
  5. Rijnders MI, Deurenberg RH, Boumans ML, Hoogkamp-Korstanje JA, Beisser PS, Stobberingh EE; Antibiotic Resistance Surveillance Group. Flucloxacillin, still the empirical choice for putative Staphylococcus aureus infections in intensive care units in the Netherlands. J Antimicrob Chemother. 2009 Nov;64(5):1029-34.
  6. Kerremans JJ, van der Bij AK, Goessens W, Verbrugh HA, Vos MC. Immediate incubation of blood cultures outside routine laboratory hours of operation accelerates antibiotic switching. J Clin Microbiol. 2009 Nov;47(11):3520-3.
  7. Vos MC, Behrendt MD, Melles DC, Mollema FP, de Groot W, Parlevliet G, Ott A, Horst-Kreft D, van Belkum A, Verbrugh HA. 5 years of experience implementing a methicillin-resistant Staphylococcus aureus search and destroy policy at the largest university medical center in the Netherlands. Infect Control Hosp Epidemiol. 2009 Oct;30(10):977-84.
  8. Ammerlaan H, Seifert H, Harbarth S, Brun-Buisson C, Torres A, Antonelli M, Kluytmans J, Bonten M; European Practices of Infections with Staphylococcus aureus (SEPIA) Study Group. Adequacy of antimicrobial treatment and outcome of Staphylococcus aureus bacteremia in 9 Western European countries. Clin Infect Dis. 2009 Oct 1;49(7):997-1005.
  9. Van de Beek D, Wijdicks EF, Vermeij FH, de Haan RJ, Prins JM, Spanjaard L, Dippel DW, Nederkoorn PJ. Preventive antibiotics for infections in acute stroke: a systematic review and meta-analysis. Arch Neurol. 2009 Sep;66(9):1076-81. Review.
  10. De Smet AM, Hopmans TE, Minderhoud AL, Blok HE, Gossink-Franssen A, Bernards AT, Bonten MJ. Decontamination of the digestive tract and oropharynx: hospital acquired infections after discharge from the intensive care unit. Intensive Care Med. 2009 Sep;35(9):1609-13.
  11. Derde LP, Bonten MJ. Oropharyngeal decontamination in intensive care patients: less is not more. Crit Care. 2009;13(5):183.
  12. De Jong BM, van der Ent CK, van der Zalm MM, van Putte-Katier N, Verheij TJ, Kimpen JL, Uiterwaal CS; WHISTLER study group. Respiratory symptoms in young infancy: child, parent and physician related determinants of drug prescription in primary care. Pharmacoepidemiol Drug Saf. 2009 Jul;18(7):610-8.
  13. Van der Zalm MM, Uiterwaal CS, Wilbrink B, de Jong BM, Verheij TJ, Kimpen JL, van der Ent CK. Respiratory pathogens in respiratory tract illnesses during the first year of life: a birth cohort study. Pediatr Infect Dis J. 2009 Jun;28(6):472-6.
  14. Smeets HM, Kuyvenhoven MM, Akkerman AE, Welschen I, Schouten GP, van Essen GA, Verheij TJ. Intervention with educational outreach at large scale to reduce antibiotics for respiratory tract infections: a controlled before and after study. Fam Pract. 2009 Jun;26(3):183-7.
  15. Tromp M, Natsch S, van Achterberg T. The preparation and administration of intravenous drugs before and after prot ocol implementation. Pharm World Sci. 2009 Jun;31(3):413-20.
  16. Muller AE, Oostvogel PM, DeJongh J, Mouton JW, Steegers EA, Dörr PJ, Danhof M, Voskuyl RA. Pharmacokinetics of amoxicillin in maternal, umbilical cord, and neonatal sera. Antimicrob Agents Chemother. 2009 Apr;53(4):1574-80.
  17. Pagani L, Gyssens IC, Huttner B, Nathwani D, Harbarth S. Navigating the Web in search of resources on antimicrobial stewardship in health care institutions. Clin Infect Dis. 2009 Mar 1;48(5):626-32. Review.
  18. Roede BM, Bresser P, Prins JM, Schellevis F, Verheij TJ, Bindels PJ. Reduced risk of next exacerbation and mortality associated with antibiotic use in COPD. Eur Respir J. 2009 Feb;33(2):282-8.
  19. De Smet AM, Kluytmans JA, Cooper BS, Mascini EM, Benus RF, van der Werf TS, van der Hoeven JG, Pickkers P, Bogaers-Hofman D, van der Meer NJ, Bernards AT, Kuijper EJ, Joore JC, Leverstein-van Hall MA, Bindels AJ, Jansz AR, Wesselink RM, de Jongh BM, Dennesen PJ, van Asselt GJ, te Velde LF, Frenay IH, Kaasjager K, Bosch FH, van Iterson M, Thijsen SF, Kluge GH, Pauw W, de Vries JW, Kaan JA, Arends JP, Aarts LP, Sturm PD, Harinck HI, Voss A, Uijtendaal EV, Blok HE, Thieme Groen ES, Pouw ME, Kalkman CJ, Bonten MJ. Decontamination of the digestive tract and oropharynx in ICU patients. N Engl J Med. 2009 Jan 1;360(1):20-31.
  20. Muller AE, Dörr PJ, Mouton JW, De Jongh J, Oostvogel PM, Steegers EA, Voskuyl RA, Danhof M. The influence of labour on the pharmacokinetics of intravenously administered amoxicillin in pregnant women. Br J Clin Pharmacol. 2008 Dec;66(6):866-74.
  21. Bruns AH, Oosterheert JJ, El Moussaoui R, Opmeer BC, Hoepelman AI, Prins JM. Pneumonia Recovery; Discrepancies in Perspectives of the Radiologist, Physician and Patient. J Gen Intern Med. 2009 Dec 5.
  22. Bootsma AM, Laguna Pes MP, Geerlings SE, Goossens Antibiotic prophylaxis in urologic procedures: a systematic review. A. Eur Urol. 2008 Dec;54(6):1270-86. Review.
  23. Knottnerus BJ, Bindels PJ, Geerlings SE, Moll van Charante EP, ter Riet G. Optimizing the diagnostic work-up of acute uncomplicated urinary tract infections. BMC Fam Pract. 2008 Dec 8;9:64.
  24. Roede BM, Bresser P, Bindels PJ, Kok A, Prins M, ter Riet G, Geskus RB, Herings RM, Prins JM. Antibiotic treatment is associated with reduced risk of a subsequent exacerbation in obstructive lung disease: an historical population based cohort study. Thorax. 2008 Nov;63(11):968-73.
  25. Prins JM, Degener JE, de Neeling AJ, Gyssens IC; SWAB Board. Experiences with the Dutch Working Party on antibiotic policy (SWAB). Euro Surveill. 2008 Nov 13;13(46).
  26. Tromp M, Bleeker-Rovers CP, van Achterber T, Kullberg BJ, Hulscher M, Pickkers P. Internal medicine residents' knowledge about sepsis: effects of a teaching intervention. Neth J Med. 2009 Oct;67(9):312-5.
  27. Gyssens IC. All EU hands to the EU pumps: the Science Academies of Europe (EASAC) recommend strong support of research to tackle antibacterial resistance. Clin Microbiol Infect. 2008 Oct;14(10):889-91.
  28. Ong DS, Kuyvenhoven MM, van Dijk L, Verheij TJ. Antibiotics for respiratory, ear and urinary tract disorders and consistency among GPs. J Antimicrob Chemother. 2008 Sep;62(3):587-92.
  29. Verbrugh HA. Prevention of Staphylococcus aureus burn wound colonization by nasal mupirocin. Burns. 2008 Sep;34(6):835-9.
  30. Kooistra-Smid AM, van Zanten E, Ott A, van Dijk SR, Beerthuizen GI, Vogels WH, van Belkum A,
    Knottnerus BJ, Nys S, Ter Riet G, Donker G, Geerlings SE, Stobberingh E. Fosfomycin tromethamine as second agent for the treatment of acute, uncomplicated urinary tract infections in adult female patients in The Netherlands? J Antimicrob Chemother. 2008 Aug;62(2):356-9.
  31. Van Rijen MM, Kluytmans JA. New approaches to prevention of staphylococcal infection in surgery. Curr Opin Infect Dis. 2008 Aug;21(4):380-4. Review.
  32. Brüggemann RJ, Donnelly JP, Aarnoutse RE, Warris A, Blijlevens NM, Mouton JW, Verweij PE, Burger DM. Therapeutic drug monitoring of voriconazole. Ther Drug Monit. 2008 Aug;30(4):403-11. Review.
  33. Visscher S, Kruisheer EM, Schurink CA, Lucas PJ, Bonten MJ. Predicting pathogens causing ventilator-associated pneumonia using a Bayesian network model. J Antimicrob Chemother. 2008 Jul;62(1):184-8.
  34. Hadi U, Duerink DO, Lestari ES, Nagelkerke NJ, Keuter M, Huis In't Veld D, Suwandojo E, Rahardjo E, van den Broek P, Gyssens IC; Antimicrobial Resistance in Indonesia: Prevalence and Prevention. Audit of antibiotic prescribing in two governmental teaching hospitals in Indonesia. Clin Microbiol Infect. 2008 Jul;14(7):698-707.
  35. Hadi U, Keuter M, van Asten H, van den Broek P; Study Group 'Antimicrobial resistance in Indonesia: Prevalence and Prevention' (AMRIN). Optimizing antibiotic usage in adults admitted with fever by a multifaceted intervention in an Indonesian governmental hospital. Trop Med Int Health. 2008 Jul;13(7):888-99.
  36. Schneeberger C, Stolk RP, Devries JH, Schneeberger PM, Herings RM, Geerlings SE. Differences in the pattern of antibiotic prescription profile and recurrence rate for possible urinary tract infections in women with and without diabetes. Diabetes Care. 2008 Jul;31(7):1380-5.
  37. De Pauw B, Walsh TJ, Donnelly JP, Stevens DA, Edwards JE, Calandra T, Pappas PG, Maertens J, Lortholary O, Kauffman CA, Denning DW, Patterson TF, Maschmeyer G, Bille J, Dismukes WE, Herbrecht R, Hope WW, Kibbler CC, Kullberg BJ, Marr KA, Muñoz P, Odds FC, Perfect JR, Restrepo A, Ruhnke M, Segal BH, Sobel JD, Sorrell TC, Viscoli C, Wingard JR, Zaoutis T, Bennett JE; European Organization for Research and Treatment of Cancer/Invasive Fungal Infections Cooperative Group; National Institute of Allergy and Infectious Diseases Mycoses Study Group (EORTC/MSG) Consensus Group. Revised definitions of invasive fungal disease from the European Organization for Research and Treatment of Cancer/Invasive Fungal Infections Cooperative Group and the National Institute of Allergy and Infectious Diseases Mycoses Study Group (EORTC/MSG) Consensus Group. Clin Infect Dis. 2008 Jun 15;46(12):1813-21.
  38. Uijen JH, van Duijn HJ, Kuyvenhoven MM, Schellevis FG, van der Wouden JC. Characteristics of children consulting for cough, sore throat, or earache. Br J Gen Pract. 2008 Apr;58(549):248-54. Erratum in: Br J Gen Pract. 2008 Jun;58(551):438.
  39. Deschepper R, Grigoryan L, Lundborg CS, Hofstede G, Cohen J, Kelen GV, Deliens L, Haaijer-Ruskamp FM. Are cultural dimensions relevant for explaining cross-national differences in antibiotic use in Europe? BMC Health Serv Res. 2008 Jun 6;8:123.
  40. Van der Kooi TI, Koningstein M, Lindemans A, Notermans DW, Kuijper E, van den Berg R, Boshuizen H, Filius PM, van den Hof S. Antibiotic use and other risk factors at hospital level for outbreaks with Clostridium difficile PCR ribotype 027. J Med Microbiol. 2008 Jun;57(Pt 6):709-16.
  41. Grigoryan L, Burgerhof JG, Degener JE, Deschepper R, Lundborg CS, Monnet DL, Scicluna EA, Birkin J, Haaijer-Ruskamp FM; Self-Medication with Antibiotics and Resistance (SAR) Consortium. Determinants of self-medication with antibiotics in Europe: the impact of beliefs, country wealth and the healthcare system. J Antimicrob Chemother. 2008 May;61(5):1172-9.
  42. El Moussaoui R, Roede BM, Speelman P, Bresser P, Prins JM, Bossuyt PM. Short-course antibiotic treatment in acute exacerbations of chronic bronchitis and COPD: a meta-analysis of double-blind studies. Thorax. 2008 May;63(5):415-22.
  43. Hermanides HS, Hulscher ME, Schouten JA, Prins JM, Geerlings SE. Development of quality i ndicators for the antibiotic treatment of complicated urinary tract infections: a first step to measure and improve care. Clin Infect Dis. 2008 Mar 1;46(5):703-11.
  44. Van Rijen MM, Bonten M, Wenzel RP, Kluytmans JA. Intranasal mupirocin for reduction of Staphylococcus aureus infections in surgical patients with nasal carriage: a systematic review. J Antimicrob Chemother. 2008 Feb;61(2):254-61.
  45. Kerremans JJ, Verboom P, Stijnen T, Hakkaart-van Roijen L, Goessens W, Verbrugh HA, Vos MC. Rapid identification and antimicrobial susceptibility testing reduce antibiotic use and accelerate pathogen-directed antibiotic use. J Antimicrob Chemother. 2008 Feb;61(2):428-35.
  46. Muller AE, DeJongh J, Oostvogel PM, Voskuyl RA, Dörr PJ, Danhof M, Mouton JW. Amoxicillin pharmacokinetics in pregnant women with preterm premature rupture of the membranes. Am J Obstet Gynecol. 2008 Jan;198(1):108.e1-6.
  47. Wertheim HF, Ammerlaan HS, Bonten MJ, van den Broek PJ, Troelstra A, Vandenbroucke-Grauls CM, Vos MC, Nouwen JL, Kluytmans JA. Optimisation of the antibiotic policy in the Netherlands. XII. The SWAB guideline for antimicrobial eradication of MRSA in carriers. Ned Tijdschr Geneeskd. 2008; 152: 2667-71
  48. Koning CJ, Jonkers DM, Stobberingh EE, Mulder L, Rombouts FM, Stockbrügger RW. The effect of a multispecies probiotic on the intestinal microbiota and bowel movements in healthy volunteers taking the antibiotic amoxycillin. Am J Gastroenterol. 2008 Jan;103(1):178-89.
  49. Van Kasteren MEE, Manniën J, Ott A, Kullberg BJ, de Boer AS, Gyssens IC. Antibiotic prophylaxis and the risk for surgical site infections following total hip arthroplasty. Timely administration is the most important factor. Clin Infect Dis 2007;44(7):921-7.
  50. Schouten JA, Hulscher ME, Trap-Liefers J, Akkermans RP, Kullberg BJ, Grol RP, Van der Meer JW. Tailored interventions to improve antibiotic use for lower respiratory tract infections in hospitals: a cluster-randomized, controlled trial. Clin Infect Dis 2007;44(7):931-41
  51. Manniën J, Van Kasteren MEE, Nagelkerke NJ, Gyssens IC, Kullberg BJ, Wille JC, De Boer AS. The effect of optimized antibiotic prophylaxis on the incidence of surgical site infections. Infect Control Hosp Epidemiol 2006;28:36-41
  52. Oosterheert JJ, Bonten MJ, Schneider MM, Buskes E, Lammers JW, Hustinx WM, Kramer MH, Prins JM, Slee PH, Kaasjger K, Hoepelman AI. Effectiveness of early switch from intravenous to oral antibiotics in severe community acquired pneumonia: multicentre randomised trial. BMJ 2006;333(7580):1193.
  53. Roede BM, Bindels PJ, Brouwer HJ, Bresser P, De Borgie CA, Prins JM. Antibiotics and steroids for exacerbations of COPD in primary care: compliance with Dutch guidelines. Br J Gen Pract 2006;56(530):662-5.
  54. Bonten MJ. Selective digestive tract decontamination -will it prevent infection with multidrug-resistant gram-negative pathogens but still be applicable in institutions where methicillin-resistant Staphylococcus aureus and vancomycin-resistant enterococci are endemic? Clin Infect Dis 2006;43 Suppl 2:S70-4.
  55. El Moussaoui R, De Borgie CA, Van den Broek P, Hustinx WN, Van den Berk GE, Poley JW, Van den Berg B, Krouwels FH, Bonten MJ, Weenink C, Bossuyt PM, Speelman P, Opmeer BC, Prins JM . Effectiveness of discontinuing antibiotic treatment after three days versus eight days in mild to moderate-severe community acquired pneumonia: randomised, double blind study. BMJ 2006;332(7554):1355.
  56. Mol PG, Denig P, Gans RO, Nannanpanday PV, Degener JE, Laseur M, Haaijer-Ruskamp FM. Limited effect of patient and disease characteristics on compliance with hospital antimicrobial guidelines. E ur J Clin Pharmacol 2006;62(4):297-305.
  57. Bonten MJ, Prins JM. Antibiotics in pandemic flu. BMJ 2006 Feb 4;332(7536):248-9.
  58. Van Kasteren MEE, Mannien J, Kullberg BJ, De Boer AS, Nagelkerke NJ, Ridderhof M, Wille JC, Gyssens IC. Quality improvement of surgical prophylaxis in Dutch hospitals: evaluation of a multi-site intervention by time series analysis. J Antimicrob Chemother 2005; 56:1094-1102
  59. Schouten J, Hulscher M, Kullberg BJ, Cox A, Gyssens IC, Van der Meer JWM, Grol R. Understanding variation in quality of antibiotic use for community-acquired pneumonia: effect of patient, professional and hospital factors. J Antimicrob Chemother 2005; 56:575-582
  60. Mol PG, Wieringa JE, Nannanpanday PV, Gans RO, Degener JE, Laseur M, Haaijer-Ruskamp FM. Improving compliance with hospital antibiotic guidelines: a time-series intervention analysis. J Antimicrob Chemother. 2005 Apr;55(4):550-7.
  61. Vogtlander NP, Van Kasteren ME, Natsch S, Kullberg BJ, Hekster YA, Van der Meer JWM. Improving the process of antibiotic therapy in daily practice: interventions to optimize timing, dosage adjustment to renal function and switch therapy. Arch Intern Med.2004 Jun 14;164(11):1206-12.
  62. Wertheim HF, Vos MC, Boelens HA, Voss A, Vandenbroucke-Grauls CM, Meester MH, Kluytmans JA, Van Keulen PH, Verbrugh HA. Low prevalence of m ethicillinresistant Sta p hylococcus aureus (MRSA) at hospital admission in the Netherlands, the value of search and destroy and restrictive antibiotic use. J Hosp Infect.2004 Apr;56(4):321-5.
  63. Mol PG, Rutten WJ, Gans RO, Degener JE, Haaijer-Ruskamp FM. Adherence barriers to antimicrobial treatment guidelines in teaching hospital, the Netherlands. Emerg Infect Dis. 2004 Mar;10(3):522-5.
  64. Natsch S, Kullberg BJ, Hekster YA, Van der Meer JWM. Selecting outcome parameters in studies aimed at improving rational use of antibiotics - practical considerations. J Clin Pharm Ther. 2003 Dec;28(6):475-8.
  65. Van Kasteren ME, Kullberg BJ, De Boer AS, Mintjes-de Groot J, Gyssens IC. Adherence to local hospital guidelines for surgical antimicrobial prophylaxis: a multicentre audit in Dutch hospitals. J Antimicrob Chemother.2003 Jun;51(6):1389-96. Epub 2003 May 13.
  66. Van der Meer JWM, Gyssens IC. Quality of antimicrobial drug prescription in hospital. Clin Microbiol Infect. 2001;7 Suppl. 6:12-5.
  67. Natsch S, Steeghs MH, Hekster YA, Meis JF, Van der Meer JWM, Kullberg BJ. Use of fluconazole in daily practice: still room for improvement. J Antimmicrob Chemother. 2001 Aug;48(2):303-10.
  68. De Man P, Verhoeven BA, Verbrugh HA, Vos MC, Van den Anker JN. An antibiotic policy to prevent emergence of resistant bacilli. Lancet 2000; 355:973-8.
  69. Goossens H. Antibiotic resistance and policy in Belgium. Verh K Acad Geneeskd Belg 2000; 62:439-69
  70. Natsch S, Kullberg BJ, Meis JF, Van der Meer JWM. Earlier initiation of antibiotic treatment for severe infections after interventions to improve the organization and specific guidelines in the emergency department. Arch Intern med. 2000 May 8; 160(9);1317-20.
  71. Gyssens IC, Kullberg BJ, Van der Meer JWM. {Clinical results and costs due to improved antibiotics policies}. Ned Tijdschr Geneeskd 1999; 143:2361-4.